| 发明名称 |
COMBINATION THERAPY OF AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABINE AND/OR MITOXANTRONE |
| 摘要 |
<p>PROBLEM TO BE SOLVED: To provide the combination therapy for the treatment of cancer.SOLUTION: This invention provides the combination therapy of an afucosylated CD20 antibody with fludarabine and/or mitoxantrone for the treatment of cancer, particularly the combination therapy of a CD20 expressing cancer using an afucosylated humanized B-Ly1 antibody and fludarabine and/or mitoxantrone.</p> |
| 申请公布号 |
JP2014141497(A) |
申请公布日期 |
2014.08.07 |
| 申请号 |
JP20140040897 |
申请日期 |
2014.03.03 |
| 申请人 |
ROCHE GLYCART AG |
发明人 |
MARTIN DREYLING;DANIEL ALEXANDER HEINRICH;FRANK HERTING;CHRISTIAN KLEIN |
| 分类号 |
A61K39/395;A61K31/136;A61K31/675;A61K31/7076;A61K45/00;A61P35/00;A61P35/02;A61P43/00;C07K16/28 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
